sb 203580 has been researched along with ovalbumin in 4 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 19,565 | 63 | 5,664 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belvisi, MG; Birrell, MA; Escott, KJ; Foster, ML; Sargent, CA; Webber, SE | 1 |
| Kawakami, Y; Ohkusu-Tsukada, K; Takahashi, K; Toda, M; Udono, H | 1 |
| Gao, X; Li, N; Zhang, J | 1 |
| Chen-Yu Hsu, A; Guan, X; Guo, Y; Pang, Z; Ran, N; Wang, F; Wang, G; Wang, Z; Yuan, Y; Zheng, R | 1 |
4 other study(ies) available for sb 203580 and ovalbumin
| Article | Year |
|---|---|
Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage; Cell Movement; Disease Models, Animal; Enzyme Inhibitors; Female; Hypersensitivity; Imidazoles; Mitogen-Activated Protein Kinases; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Tumor Necrosis Factor-alpha | 2000 |
Targeted inhibition of IL-10-secreting CD25- Treg via p38 MAPK suppression in cancer immunotherapy.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Animals; Clonal Anergy; Forkhead Transcription Factors; Imidazoles; Immunotherapy; Immunotherapy, Adoptive; Interleukin-10; Interleukin-2 Receptor alpha Subunit; Lymphocyte Depletion; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred Strains; Mice, Transgenic; Minor Lymphocyte Stimulatory Antigens; Molecular Sequence Data; Neoplasm Proteins; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Pyridines; Receptors, Antigen, T-Cell, alpha-beta; Superantigens; T-Lymphocytes, Regulatory; Toll-Like Receptor 9; Tumor Escape | 2010 |
SB203580, a p38MAPK inhibitor, attenuates olfactory dysfunction by inhibiting OSN apoptosis in AR mice (activation and involvement of the p38 mitogen-activated protein kinase in olfactory sensory neuronal apoptosis of OVA-induced allergic rhinitis).
Topics: Animals; Apoptosis; Female; Imidazoles; Irritants; MAP Kinase Signaling System; Mice, Inbred BALB C; Olfaction Disorders; Olfactory Receptor Neurons; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rhinitis, Allergic; Signal Transduction; Smell | 2019 |
Combined treatment with SB203580 and dexamethasone suppresses non-typeable Haemophilus influenzae-induced Th17 inflammation response in murine allergic asthma.
Topics: Animals; Asthma; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Imidazoles; Inflammation; Lung; Mice; Mucin 5AC; Mucin-5B; Neutrophils; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Pyridines; Respiratory Mucosa; Signal Transduction; Symptom Flare Up; Th17 Cells | 2019 |